Showing results (131-140 of 518) with videos related to
Sort By:
Pageof 52
The American Journal of Cardiology|July 1, 1988
Cardiac pacing practices in the United States in 1985V Parsonnet, A D Bernstein, D GalassoCancer Immunology, Immunotherapy : CII|June 1, 1997
Active immunization of metastatic melanoma patients with interleukin-2-transduced allogeneic melanoma cells: evaluation of efficacy and tolerabilityF Belli, F Arienti, J Sulé-Suso, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1988
Lack of suppressive activity of human primary melanoma cells on the activation of autologous lymphocytesD Taramelli, A Mazzocchi, C Clemente, et al.British Journal of Cancer|July 1, 1986
Characterization of a doxorubicin-resistant murine melanoma line: studies on cross-resistance and its circumventionR Supino, E Prosperi, F Formelli, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1997
TCR beta-chain variable region-driven selection and massive expansion of HLA-class I-restricted antitumor CTL lines from HLA-A*0201+ melanoma patientsC Maccalli, C Farina, M Sensi, et al.Annali Dell'Istituto Superiore Di Sanita|January 1, 1990
Adoptive immunotherapeutic treatments with interleukin 2 and lymphocytes in a mouse colonic adenocarcinoma modelM Rodolfo, C Salvi, C Bassi, et al.Experimental and Clinical Immunogenetics|January 1, 1990
H-2 class I gene analysis in 3-methylcholanthrene-induced murine fibrosarcomasC Castelli, F Mazzucchelli, M Sensi, et al.International Journal of Cancer|April 1, 1993
T-cell-receptor engagement and tumor ICAM-1 up-regulation are required to by-pass low susceptibility of melanoma cells to autologous CTL-mediated lysisA Anichini, R Mortarini, S Alberti, et al.Cancer Research|August 15, 1992
Role of the alpha 5 beta 1 integrin receptor in the proliferative response of quiescent human melanoma cells to fibronectinR Mortarini, A Gismondi, A Santoni, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1992
Postsurgical adjuvant chemoimmunotherapy with recombinant interleukin-2 and 1,3-bis-(2-chloroethyl)-1-nitrosourea on spontaneous metastases of a non-immunogenic murine tumourG Acerbis, L Cleris, M Rodolfo, et al.Pageof 52